Stay updated on Pembrolizumab in Kaposi's Sarcoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Kaposi's Sarcoma Clinical Trial page.

Latest updates to the Pembrolizumab in Kaposi's Sarcoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study content with a basic error screen. A Home link and standard footer appear, indicating the page is currently inaccessible.SummaryDifference19%

- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedAdded 2016 ( U.S. NIH Grant/Contract ) and Revision: v3.6.6, while Revision: v3.6.5 was removed. These updates reflect funding disclosures and versioning metadata rather than substantive changes to the study details.SummaryDifference0.1%

- Check51 days agoChange Detected- The page revision updated from v3.6.4 to v3.6.5, signaling a new software release of the page. - The update likely includes minor fixes or improvements but does not alter the study content or visible user-facing features.SummaryDifference0.1%

- Check66 days agoChange DetectedThe page revision has been updated from v3.6.3 to v3.6.4, signaling a minor update to the ClinicalTrials.gov entry. This change does not modify the study details, eligibility criteria, or other substantive content.SummaryDifference0.1%

- Check87 days agoChange DetectedThe page's revision label was updated to v3.6.3, indicating a new version of the page. The change is limited to metadata/versioning and does not alter the study information displayed.SummaryDifference0.1%

- Check95 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.2, indicating a minor software update to the page.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Kaposi's Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Kaposi's Sarcoma Clinical Trial page.